Stock To Watch: Amgen Inc. (NASDAQ:AMGN)


The leading market experts have placed a mean price target of $183.88 on Amgen Inc. (NASDAQ:AMGN) stock. This price level, which is estimated to be attained in one-year indicates the mean of stock opinions given by the companies included in the First Call survey. The renowned research firms have predicted earnings of $2.77 a share for the upcoming quarter and $11.18 for the current fiscal. Technical View The technical analysis of Amgen Inc. plainly substantiates that the 50-day moving average of Amgen Inc. is $153.28, and stock is hovering 2.30 or +1.50% distant from $153.28. It is noted that the 200-day MA is $152.77, and Amgen Inc. stock is $2.81 or +1.84% off from this point. Amgen Inc. (NASDAQ:AMGN) 52-week high is $181.81 and the 52-week low is $130.09. This explains if the stock moves $-26.23, it will post a 52-week high. In event of $+19.59% points decline, a 52-week low will be hit. Taking the Valuation Aspect To emphasize the valuation of Amgen Inc., shareholders can apply financial tool known as price-to-earnings ratio. This financial ratio assesses stock’s valuation by considering the relative expense of the stock. Following this ratio, Amgen Inc. (NASDAQ:AMGN) ratio came in at 16.46. The stock last ended the trading session at $155.58 and registered a market cap of $116.87B. To appraise firm’s growth, the shareholders take help of the Price-to-Earnings-Growth ratio. When a stock has a higher PEG ratio, it is suggestive of lower stock appreciation in approaching sessions. A stock comes in the group of undervalued stocks when its PEG ratio falls in between 0 and 1. Amgen Inc. (NASDAQ:AMGN) PEG ratio is at 1.67.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 3 times, 1 visits today)